28
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Complications of cirrhosis

Why they occur and what to do about them

, MD & , MD
Pages 209-224 | Published online: 30 Jun 2015

References

  • Centers for Disease Control. Deaths and hospitalizations from chronic liver disease and cirrhosis—United States, 1980–1989. JAMA 1993; 269(5): 569, 572
  • Czaja AJ, Wolf AM, Baggenstoss AH. Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 1980; 55(6): 360–4
  • Fisher MR, Gore RM. Computed tomography in the evaluation of cirrhosis and portal hypertension. J Clin Gastroenterol 1985; 7(2): 173–81
  • Dudley FJ. Pathophysiology of ascites formation. Gastroenterol Clin North Am 1992; 21(1): 215–35
  • Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994; 20(5): 1343–50
  • North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319(15): 983–9
  • Franco-Italian Multicenter Study Group. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991; 324(22): 1532–8
  • Angelico M, Carli L, Piat C, et al. lsosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993; 104(5): 1460–5
  • Sung JJ, Chung SC, Lai CW, et al. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993; 342(8872): 637–41
  • Saari A, Kivilaakso E, Inberg M, et al. Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol 1990; 85(7): 804–7
  • Laine L, el-Newihi HM, Migikovsky B, et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119(1): 1–7
  • Chojkier M, Conn HO. Esophageal tamponade in the treatment of bleeding varices: a decadal progress report. Dig Dis Sci 1980; 25(4): 267–72
  • Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996; 334(25): 1624–9
  • Veterans Affairs Cooperative Variceal Sclerotherapy Group. Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. Hepatology 1994; 20(3): 618–25
  • Lind CD. Transjugular intrahepatic portosystemic shunt (TIPS) in the management of esophageal variceal hemorrhage. Compr Ther 1995; 21(4): 189–94
  • Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117(3): 215–20
  • D'Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31(5): 468–75
  • Gines P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94(6): 1493–502
  • Smadja C, Franco D. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis: a prospective study on 140 patients. Ann Surg 1985; 201(4): 488–93
  • Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332(18): 1192–7 [Erratum, N Engl J Med 1995; 332(23): 1587]
  • Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106(5): 1277–83
  • Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16(3): 724–7
  • Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 100 patients. Gastroenterology 1991; 100(6): 1737–42
  • Tito L, Rimola A, Gines P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8(1): 27–31
  • Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12(4 Pt 1): 716–24
  • Singh N, Gayowski T, Yu VL, et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995; 122(8): 595–8
  • Weber FL Jr, Banwell JG, Fresard KM, et al. Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and' lactulose plus neomycin. J Lab Clin Med 1987; 110(3): 259–63
  • Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105(1): 229–36
  • Abrains GA, Jaffe CC, Hoffer PB, et al. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109(4): 1283–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.